Discussion of Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
The results suggest that hydroxychloroquine is not an effective treatment for hospitalized COVID-19 patients. Since there is little difference in primary outcome between the patients who received hydroxychloroquine and those who did not, it can be concluded that there is insignificant mortality benefit. Patients who received hydroxychloroquine also had longer duration of hospital stay and an increased risk of requiring invasive mechanical ventilation (if not already receiving invasive mechanical ventilation) and death. As a result, these trails have been discontinued since June 5th, 2020.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Methods of Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Results of Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Discussion of Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Limitations of Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.